Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

2024-10-07
0:00
11:00
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

Fler avsnitt från "Healthspan"